Neuro-psychological expertise
Behavioral testing and imaging
Behavioral testing
Do you think that integrating neuropsychological tools into clinical trials is essential? Our platform relies on several neuropsychologists and a series of adapted standardized tests.
Evaluation of specific cognitive functions
altered by cancer and cancer treatments using adapted, standardized cognitive tests
Examination of the effect
of short- and longer-term treatments on cognition
Evaluation of cognitive impairment
perceived by patients and of the impact of this impairment on quality of life
Identification of the relationship between
perceived impairment and objective cognitive scores
Consideration of patient psychological status
(anxiety, depression, fatigue…) to specifically grasp the impact of cancer and cancer treatments on cognition
Study of the influence of cognitive reserve
and metacognition on the incidence of cognitive impairment
Cognitive rehabilitation
as treatment
“ We use a dozen internationally-recognized standardized tests that enable thorough cognitive evaluation. Long-term memory, vision, verbal skills, attention, executive functions….Our original approach focuses on metacognition tasks while controlling patient anxiety, depression and fatigue as well as the effect of treatments”
Imaging
Do you also think essential to identify and understand the anatomical abnormalities and functional brain impairment caused by cancer and cancer treatments ? Neuro-imaging aims to complement the study of cognitive behavioural impairment : anatomical and functional brain imaging studies improve the understanding of behavioural impairment.
Study of functional brain impairment
using brain imaging protocols: fMRI, PET (Positron Emission Tomography), currently in development
Study of anatomical brain impairment
following cancer and cancer treatments (techniques: VBM and DTI)
Comparing anatomical and functional brain
impairment with the results of cognitive behavioural tests
“ Our approach is original: we aim to understand cognitive impairment related to cancer by combining neuro-imaging and neuropsychology methods. Since 2007, the CNO’s experts have been working together to improve the understanding of the mechanisms involved. We are also pioneers in this area : in cancer and cognition, the complementarity of our expertise is truly unique within the international scientific community”